Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GoodRx Holdings, Inc.GDRX · Entity 4838 | President, Healthcare | October 19, 2021 | October 21, 2021 |
| MCKESSON CORPMCK · Entity 2904 | EVP, Chief Strategy & BDO | May 24, 2019 | May 28, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GoodRx Holdings, Inc.
Report date October 19, 2021 · Filed October 21, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2021-10-20 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2021-10-19 · Exercise / conversion · Acquired 100 · Balance 100 Row 2 · 2021-10-19 · Sale · Disposed 100 · Balance 0 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Row 3 · 2021-10-20 · Exercise / conversion · Acquired 16,300 · Balance 16,300 Row 4 · 2021-10-20 · Sale · Disposed 16,300 · Balance 0 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.84 · Expires 2030-06-15 | Direct | 305,884 |
Reported balance
After 2021-10-19 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2021-10-19 · Exercise / conversion · Disposed 100 · Balance 305,884 F2: The option vested and became exercisable as to 25,000 shares on the closing date of the Issuer's initial public offering of securities, and vested or will vest as to 1/48th of the original 400,000 shares monthly thereafter until fully vested on June 10, 2024. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.84 · Expires 2030-06-15 | Direct | 289,584 |
Reported balance
After 2021-10-19 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2021-10-19 · Exercise / conversion · Disposed 16,300 · Balance 289,584 F2: The option vested and became exercisable as to 25,000 shares on the closing date of the Issuer's initial public offering of securities, and vested or will vest as to 1/48th of the original 400,000 shares monthly thereafter until fully vested on June 10, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2: The option vested and became exercisable as to 25,000 shares on the closing date of the Issuer's initial public offering of securities, and vested or will vest as to 1/48th of the original 400,000 shares monthly thereafter until fully vested on June 10, 2024.
MCKESSON CORP
Report date May 24, 2019 · Filed May 28, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,805 |
Ending reported balance
After 2019-05-24 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2019-05-24 · Exercise / conversion · Acquired 1,232 · Balance 5,232 Row 2 · 2019-05-24 · Tax withholding · Disposed 427 · Balance 4,805 F1: This transaction represents a withholding of shares to cover taxes applicable to a vesting of RSUs also reported on this Form 4. |
| Restricted Stock Units (RSUs)SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2019-05-24 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2019-05-24 · Exercise / conversion · Disposed 1,232 · Balance 0 F2: RSU award granted 5/24/2016 vested 100% on 5/24/2019. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction represents a withholding of shares to cover taxes applicable to a vesting of RSUs also reported on this Form 4.
F2: RSU award granted 5/24/2016 vested 100% on 5/24/2019.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Change Healthcare Inc.
Report date October 03, 2022 · Filed October 05, 2022
Section 16 reporting ended · disclosed 2022-10-05. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2022-10-03 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2022-10-03 · Disposition to issuer · Disposed 10,000 · Balance 29,280 F1: On October 3, 2022, UnitedHealth Group Incorporated ("UnitedHealth Group") acquired Change Healthcare Inc. (the "Issuer") pursuant to that certain Agreement and Plan of Merger dated as of January 5, 2021 (the "Merger Agreement") by and among the Issuer, UnitedHealth Group and Cambridge Merger Sub Inc., a wholly owned subsidiary of UnitedHealth Group ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of UnitedHealth Group. At the effective time of the Merger (the "Effective Time"), each issued and outstanding share of common stock, par value $0.001 per share, of the Issuer (the "Common Stock") (other than certain excluded shares) automatically converted into the right to receive $25.75 per share in cash, without interest and less any applicable holding tax. Row 2 · 2022-10-03 · Disposition to issuer · Disposed 29,280 · Balance 0 F1: On October 3, 2022, UnitedHealth Group Incorporated ("UnitedHealth Group") acquired Change Healthcare Inc. (the "Issuer") pursuant to that certain Agreement and Plan of Merger dated as of January 5, 2021 (the "Merger Agreement") by and among the Issuer, UnitedHealth Group and Cambridge Merger Sub Inc., a wholly owned subsidiary of UnitedHealth Group ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of UnitedHealth Group. At the effective time of the Merger (the "Effective Time"), each issued and outstanding share of common stock, par value $0.001 per share, of the Issuer (the "Common Stock") (other than certain excluded shares) automatically converted into the right to receive $25.75 per share in cash, without interest and less any applicable holding tax. F2: At the Effective Time of the Merger, all deferred stock units of the Issuer automatically vested and were automatically converted into UnitedHealth Group deferred stock units calculated by taking the merger consideration of $25.75 per share of Common Stock and dividing it by the volume weighted average of the closing sale prices per share of UnitedHealth Group common stock on each of the five full consecutive trading days ending on and including the third business day prior to the Merger closing date and continue to be subject to the same terms and conditions (including settlement terms) as were applicable to the Issuer deferred stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: On October 3, 2022, UnitedHealth Group Incorporated ("UnitedHealth Group") acquired Change Healthcare Inc. (the "Issuer") pursuant to that certain Agreement and Plan of Merger dated as of January 5, 2021 (the "Merger Agreement") by and among the Issuer, UnitedHealth Group and Cambridge Merger Sub Inc., a wholly owned subsidiary of UnitedHealth Group ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of UnitedHealth Group. At the effective time of the Merger (the "Effective Time"), each issued and outstanding share of common stock, par value $0.001 per share, of the Issuer (the "Common Stock") (other than certain excluded shares) automatically converted into the right to receive $25.75 per share in cash, without interest and less any applicable holding tax.
F2: At the Effective Time of the Merger, all deferred stock units of the Issuer automatically vested and were automatically converted into UnitedHealth Group deferred stock units calculated by taking the merger consideration of $25.75 per share of Common Stock and dividing it by the volume weighted average of the closing sale prices per share of UnitedHealth Group common stock on each of the five full consecutive trading days ending on and including the third business day prior to the Merger closing date and continue to be subject to the same terms and conditions (including settlement terms) as were applicable to the Issuer deferred stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 03, 2022 Filed Oct 5, 2022 16:31 UTC | Change Healthcare Inc. CHNG · Entity 15437 | Disposition to issuerCommon Stock | 29,280 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-033008 · doc4.xml · nonDerivative · entry 2 NAGJI BANSI · CIK 0001632311 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: On October 3, 2022, UnitedHealth Group Incorporated ("UnitedHealth Group") acquired Change Healthcare Inc. (the "Issuer") pursuant to that certain Agreement and Plan of Merger dated as of January 5, 2021 (the "Merger Agreement") by and among the Issuer, UnitedHealth Group and Cambridge Merger Sub Inc., a wholly owned subsidiary of UnitedHealth Group ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of UnitedHealth Group. At the effective time of the Merger (the "Effective Time"), each issued and outstanding share of common stock, par value $0.001 per share, of the Issuer (the "Common Stock") (other than certain excluded shares) automatically converted into the right to receive $25.75 per share in cash, without interest and less any applicable holding tax. F2 · shares: At the Effective Time of the Merger, all deferred stock units of the Issuer automatically vested and were automatically converted into UnitedHealth Group deferred stock units calculated by taking the merger consideration of $25.75 per share of Common Stock and dividing it by the volume weighted average of the closing sale prices per share of UnitedHealth Group common stock on each of the five full consecutive trading days ending on and including the third business day prior to the Merger closing date and continue to be subject to the same terms and conditions (including settlement terms) as were applicable to the Issuer deferred stock units. F1 · price: On October 3, 2022, UnitedHealth Group Incorporated ("UnitedHealth Group") acquired Change Healthcare Inc. (the "Issuer") pursuant to that certain Agreement and Plan of Merger dated as of January 5, 2021 (the "Merger Agreement") by and among the Issuer, UnitedHealth Group and Cambridge Merger Sub Inc., a wholly owned subsidiary of UnitedHealth Group ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of UnitedHealth Group. At the effective time of the Merger (the "Effective Time"), each issued and outstanding share of common stock, par value $0.001 per share, of the Issuer (the "Common Stock") (other than certain excluded shares) automatically converted into the right to receive $25.75 per share in cash, without interest and less any applicable holding tax. F2 · price: At the Effective Time of the Merger, all deferred stock units of the Issuer automatically vested and were automatically converted into UnitedHealth Group deferred stock units calculated by taking the merger consideration of $25.75 per share of Common Stock and dividing it by the volume weighted average of the closing sale prices per share of UnitedHealth Group common stock on each of the five full consecutive trading days ending on and including the third business day prior to the Merger closing date and continue to be subject to the same terms and conditions (including settlement terms) as were applicable to the Issuer deferred stock units. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 16:31 UTC | Change Healthcare Inc. CHNG · Entity 15437 | Disposition to issuerCommon Stock | 10,000 | $25.75 | $257,500.00 |
DisclosureSEC source: 0000899243-22-033008 · doc4.xml · nonDerivative · entry 1 NAGJI BANSI · CIK 0001632311 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,280 F1 · price: On October 3, 2022, UnitedHealth Group Incorporated ("UnitedHealth Group") acquired Change Healthcare Inc. (the "Issuer") pursuant to that certain Agreement and Plan of Merger dated as of January 5, 2021 (the "Merger Agreement") by and among the Issuer, UnitedHealth Group and Cambridge Merger Sub Inc., a wholly owned subsidiary of UnitedHealth Group ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of UnitedHealth Group. At the effective time of the Merger (the "Effective Time"), each issued and outstanding share of common stock, par value $0.001 per share, of the Issuer (the "Common Stock") (other than certain excluded shares) automatically converted into the right to receive $25.75 per share in cash, without interest and less any applicable holding tax. Read SEC document |
| April 25, 2022 Filed Apr 27, 2022 17:06 UTC | Change Healthcare Inc. CHNG · Entity 15437 | GrantCommon Stock | 7,658 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-010879 · form4.xml · nonDerivative · entry 1 NAGJI BANSI · CIK 0001632311 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,280 F1 · shares: Represents the grant of deferred stock units that vest on April 25, 2023. The shares subject to the units will be issued to the Reporting Person after the Reporting Person's separation from service from the Issuer. Read SEC document |
| October 20, 2021 Filed Oct 21, 2021 20:52 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 16,300 | $45.00 | $733,500.00 |
DisclosureSEC source: 0000899243-21-040972 · doc4.xml · nonDerivative · entry 4 NAGJI BANSI · CIK 0001632311 · President, Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| October 20, 2021 Filed Oct 21, 2021 20:52 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 16,300 | $6.84 | $111,492.00 |
DisclosureSEC source: 0000899243-21-040972 · doc4.xml · nonDerivative · entry 3 NAGJI BANSI · CIK 0001632311 · President, Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,300 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 19, 2021 Filed Oct 21, 2021 20:52 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionStock Option (Right to Buy) · Derivative | 16,300 | $0.00 Strike: $6.84 | $0.00 |
DisclosureSEC source: 0000899243-21-040972 · doc4.xml · derivative · entry 6 NAGJI BANSI · CIK 0001632311 · President, Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 289,584 Underlying: Class A Common Stock · 16,300 shares Expires 2030-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested and became exercisable as to 25,000 shares on the closing date of the Issuer's initial public offering of securities, and vested or will vest as to 1/48th of the original 400,000 shares monthly thereafter until fully vested on June 10, 2024. Read SEC document |
| October 19, 2021 Filed Oct 21, 2021 20:52 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionStock Option (Right to Buy) · Derivative | 100 | $0.00 Strike: $6.84 | $0.00 |
DisclosureSEC source: 0000899243-21-040972 · doc4.xml · derivative · entry 5 NAGJI BANSI · CIK 0001632311 · President, Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 305,884 Underlying: Class A Common Stock · 100 shares Expires 2030-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested and became exercisable as to 25,000 shares on the closing date of the Issuer's initial public offering of securities, and vested or will vest as to 1/48th of the original 400,000 shares monthly thereafter until fully vested on June 10, 2024. Read SEC document |
| October 19, 2021 Filed Oct 21, 2021 20:52 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 100 | $45.02 | $4,502.00 |
DisclosureSEC source: 0000899243-21-040972 · doc4.xml · nonDerivative · entry 2 NAGJI BANSI · CIK 0001632311 · President, Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| October 19, 2021 Filed Oct 21, 2021 20:52 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 100 | $6.84 | $684.00 |
DisclosureSEC source: 0000899243-21-040972 · doc4.xml · nonDerivative · entry 1 NAGJI BANSI · CIK 0001632311 · President, Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 07, 2021 Filed Oct 13, 2021 01:32 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,600 | $0.00 Strike: $6.84 | $0.00 |
DisclosureSEC source: 0000899243-21-039976 · doc4.xml · derivative · entry 3 NAGJI BANSI · CIK 0001632311 · President, Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,600 Underlying: Class A Common Stock · 3,600 shares Expires 2030-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested and became exercisable as to 25,000 shares on the closing date of the Issuer's initial public offering of securities, and vested or will vest as to 1/48th of the original 400,000 shares monthly thereafter until fully vested on June 10, 2024. F4 · balance_after: The Reporting Person's prior Form 4 filed on September 16, 2021 incorrectly stated that 309,564 shares underlying this option remained after the reported transactions and should have reported 309,584 shares underlying this option after the reported transactions. Read SEC document |
| October 07, 2021 Filed Oct 13, 2021 01:32 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 3,600 | $45.05 | $162,186.84 |
DisclosureSEC source: 0000899243-21-039976 · doc4.xml · nonDerivative · entry 2 NAGJI BANSI · CIK 0001632311 · President, Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,166 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.18. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 07, 2021 Filed Oct 13, 2021 01:32 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 3,600 | $6.84 | $24,624.00 |
DisclosureSEC source: 0000899243-21-039976 · doc4.xml · nonDerivative · entry 1 NAGJI BANSI · CIK 0001632311 · President, Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,766 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 16, 2021 Filed Sep 16, 2021 23:52 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionStock Option (Right to Buy) · Derivative | 29,788 | $0.00 Strike: $6.84 | $0.00 |
DisclosureSEC source: 0000899243-21-036345 · doc4.xml · derivative · entry 10 NAGJI BANSI · CIK 0001632311 · President, Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 309,564 Underlying: Class A Common Stock · 29,788 shares Expires 2030-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option vested and became exercisable as to 25,000 shares on the closing date of the Issuer's initial public offering of securities, and vested or will vest as to 1/48th of the shares monthly thereafter until fully vested on June 10, 2024. Read SEC document |
| September 16, 2021 Filed Sep 16, 2021 23:52 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 29,788 | $45.03 | $1,341,487.69 |
DisclosureSEC source: 0000899243-21-036345 · doc4.xml · nonDerivative · entry 6 NAGJI BANSI · CIK 0001632311 · President, Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: This price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.13. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 16, 2021 Filed Sep 16, 2021 23:52 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 29,788 | $6.84 | $203,749.92 |
DisclosureSEC source: 0000899243-21-036345 · doc4.xml · nonDerivative · entry 5 NAGJI BANSI · CIK 0001632311 · President, Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,788 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2021 Filed Sep 16, 2021 23:52 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionStock Option (Right to Buy) · Derivative | 60,415 | $0.00 Strike: $6.84 | $0.00 |
DisclosureSEC source: 0000899243-21-036345 · doc4.xml · derivative · entry 9 NAGJI BANSI · CIK 0001632311 · President, Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 339,372 Underlying: Class A Common Stock · 60,415 shares Expires 2030-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option vested and became exercisable as to 25,000 shares on the closing date of the Issuer's initial public offering of securities, and vested or will vest as to 1/48th of the shares monthly thereafter until fully vested on June 10, 2024. Read SEC document |
| September 15, 2021 Filed Sep 16, 2021 23:52 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 60,415 | $45.03 | $2,720,414.95 |
DisclosureSEC source: 0000899243-21-036345 · doc4.xml · nonDerivative · entry 4 NAGJI BANSI · CIK 0001632311 · President, Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: This price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.24. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 15, 2021 Filed Sep 16, 2021 23:52 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 60,415 | $6.84 | $413,238.60 |
DisclosureSEC source: 0000899243-21-036345 · doc4.xml · nonDerivative · entry 3 NAGJI BANSI · CIK 0001632311 · President, Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,415 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 14, 2021 Filed Sep 16, 2021 23:52 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionStock Option (Right to Buy) · Derivative | 213 | $0.00 Strike: $6.84 | $0.00 |
DisclosureSEC source: 0000899243-21-036345 · doc4.xml · derivative · entry 8 NAGJI BANSI · CIK 0001632311 · President, Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 399,787 Underlying: Class A Common Stock · 213 shares Expires 2030-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option vested and became exercisable as to 25,000 shares on the closing date of the Issuer's initial public offering of securities, and vested or will vest as to 1/48th of the shares monthly thereafter until fully vested on June 10, 2024. Read SEC document |
| September 14, 2021 Filed Sep 16, 2021 23:52 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionStock Option (Right to Buy) · Derivative | 89,584 | $0.00 Strike: $6.84 | $0.00 |
DisclosureSEC source: 0000899243-21-036345 · doc4.xml · derivative · entry 7 NAGJI BANSI · CIK 0001632311 · President, Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 481,250 Underlying: Class A Common Stock · 89,797 shares Expires 2030-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option has vested and became exercisable or will vest and become exercisable with respect to the original 700,000 underlying shares of Class A common stock in equal monthly installments over a four year period that commenced on June 10, 2020. Read SEC document |
| September 14, 2021 Filed Sep 16, 2021 23:52 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 89,797 | $45.01 | $4,042,023.38 |
DisclosureSEC source: 0000899243-21-036345 · doc4.xml · nonDerivative · entry 2 NAGJI BANSI · CIK 0001632311 · President, Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.11. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 14, 2021 Filed Sep 16, 2021 23:52 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 89,797 | $6.84 | $614,211.48 |
DisclosureSEC source: 0000899243-21-036345 · doc4.xml · nonDerivative · entry 1 NAGJI BANSI · CIK 0001632311 · President, Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,797 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 22, 2021 Filed Jun 24, 2021 14:27 UTC | Change Healthcare Inc. CHNG · Entity 15437 | GrantCommon Stock | 7,136 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-005918 · form4.xml · nonDerivative · entry 1 NAGJI BANSI · CIK 0001632311 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,622 F1 · shares: Represents the grant of deferred stock units that vests on June 22, 2022. The shares subject to the units will be issued to the Reporting Person after the Reporting Person's separation from service from the Issuer. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 22:29 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionStock Option (Right to Buy) · Derivative | 54,002 | $0.00 Strike: $6.84 | $0.00 |
DisclosureSEC source: 0000899243-21-023335 · doc4.xml · derivative · entry 3 NAGJI BANSI · CIK 0001632311 · President, Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 570,834 Underlying: Class A Common Stock · 54,002 shares Expires 2030-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option has vested and became exercisable or will vest and become exercisable with respect to the original 670,834 underlying shares of Class A common stock in equal monthly installments over a four year period that commenced on June 10, 2020. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 22:29 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 54,002 | $40.21 | $2,171,296.22 |
DisclosureSEC source: 0000899243-21-023335 · doc4.xml · nonDerivative · entry 2 NAGJI BANSI · CIK 0001632311 · President, Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,166 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.48. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 22:29 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 54,002 | $6.84 | $369,373.68 |
DisclosureSEC source: 0000899243-21-023335 · doc4.xml · nonDerivative · entry 1 NAGJI BANSI · CIK 0001632311 · President, Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,168 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 02, 2021 Filed Jun 7, 2021 10:03 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionStock Option (Right to Buy) · Derivative | 45,998 | $0.00 Strike: $6.84 | $0.00 |
DisclosureSEC source: 0000899243-21-022208 · doc4.xml · derivative · entry 3 NAGJI BANSI · CIK 0001632311 · President, Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 624,836 Underlying: Class A Common Stock · 45,998 shares Expires 2030-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option has vested and became exercisable or will vest and become exercisable with respect to the original 670,834 underlying shares of Class A common stock in equal monthly installments over a four year period that commenced on June 10, 2020. Read SEC document |
| June 02, 2021 Filed Jun 7, 2021 10:03 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 45,998 | $40.07 | $1,843,116.86 |
DisclosureSEC source: 0000899243-21-022208 · doc4.xml · nonDerivative · entry 2 NAGJI BANSI · CIK 0001632311 · President, Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,166 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.29. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 02, 2021 Filed Jun 7, 2021 10:03 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 45,998 | $6.84 | $314,626.32 |
DisclosureSEC source: 0000899243-21-022208 · doc4.xml · nonDerivative · entry 1 NAGJI BANSI · CIK 0001632311 · President, Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,164 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 02, 2020 Filed Dec 15, 2020 21:15 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass B Common Stock · Derivative | 29,166 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-033894 · doc4.xml · derivative · entry 2 NAGJI BANSI · CIK 0001632311 · President, Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 29,166 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F1 · derivative.exercise_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F1 · derivative.expiration_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Read SEC document |
| November 02, 2020 Filed Dec 15, 2020 21:15 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass A Common Stock | 29,166 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-033894 · doc4.xml · nonDerivative · entry 1 NAGJI BANSI · CIK 0001632311 · President, Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,166 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 17, 2020 Filed Jun 19, 2020 16:41 UTC | Change Healthcare Inc. CHNG · Entity 15437 | GrantCommon Stock | 14,486 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-20-002931 · form4.xml · nonDerivative · entry 1 NAGJI BANSI · CIK 0001632311 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,486 F1 · shares: Represents the grant of deferred stock units that vests on June 17, 2021. The shares subject to the units will be issued to the Reporting Person after the Reporting Person's separation from service from the Issuer. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 16:34 UTC | Change Healthcare Inc. CHNG · Entity 15437 | PurchaseCommon Stock | 5,000 | $13.00 | $65,000.00 |
DisclosureSEC source: 0000899243-19-019186 · doc4.xml · nonDerivative · entry 1 Nagji Bansi · CIK 0001632311 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 F1 · kind: Reflects shares of common stock of the Issuer purchased under the Issuer's Directed Share Program in connection with the Issuer's initial public offering. Read SEC document |
| May 24, 2019 Filed May 28, 2019 23:21 UTC | MCKESSON CORP MCK · Entity 2904 | Exercise / conversionRestricted Stock Units (RSUs) · Derivative | 1,232 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001443873-19-000023 · edgar.xml · derivative · entry 3 Nagji Bansi · CIK 0001632311 · EVP, Chief Strategy & BDO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,232 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: RSU award granted 5/24/2016 vested 100% on 5/24/2019. F2 · derivative.expiration_date: RSU award granted 5/24/2016 vested 100% on 5/24/2019. Read SEC document |
| May 24, 2019 Filed May 28, 2019 23:21 UTC | MCKESSON CORP MCK · Entity 2904 | Tax withholdingCommon Stock | 427 | $129.92 | $55,475.84 |
DisclosureSEC source: 0001443873-19-000023 · edgar.xml · nonDerivative · entry 2 Nagji Bansi · CIK 0001632311 · EVP, Chief Strategy & BDO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,805 F1 · shares: This transaction represents a withholding of shares to cover taxes applicable to a vesting of RSUs also reported on this Form 4. Read SEC document |
| May 24, 2019 Filed May 28, 2019 23:21 UTC | MCKESSON CORP MCK · Entity 2904 | Exercise / conversionCommon Stock | 1,232 | $0.00 | $0.00 |
DisclosureSEC source: 0001443873-19-000023 · edgar.xml · nonDerivative · entry 1 Nagji Bansi · CIK 0001632311 · EVP, Chief Strategy & BDO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,232 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 21, 2019 Filed May 23, 2019 22:40 UTC | MCKESSON CORP MCK · Entity 2904 | GrantRestricted Stock Units (RSUs) · Derivative | 6,234 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001443873-19-000016 · edgar.xml · derivative · entry 3 Nagji Bansi · CIK 0001632311 · EVP, Chief Strategy & BD Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,234 Underlying: Common Stock · 6,234 shares Expires not disclosed F3 · derivative.exercise_date: These RSUs will vest 1/3 on 5/21/2020, 1/3 on 5/21/2021 and 1/3 on 5/21/2022. F3 · derivative.expiration_date: These RSUs will vest 1/3 on 5/21/2020, 1/3 on 5/21/2021 and 1/3 on 5/21/2022. Read SEC document |
| May 21, 2019 Filed May 23, 2019 22:40 UTC | MCKESSON CORP MCK · Entity 2904 | Tax withholdingCommon Stock | 487 | $128.33 | $62,496.71 |
DisclosureSEC source: 0001443873-19-000016 · edgar.xml · nonDerivative · entry 2 Nagji Bansi · CIK 0001632311 · EVP, Chief Strategy & BD Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 F2 · shares: This transaction represents a withholding of shares to cover taxes applicable to a vesting of PSUs also reported on this Form 4. Read SEC document |
| May 21, 2019 Filed May 23, 2019 22:40 UTC | MCKESSON CORP MCK · Entity 2904 | GrantCommon Stock | 1,407 | $0.00 | $0.00 |
DisclosureSEC source: 0001443873-19-000016 · edgar.xml · nonDerivative · entry 1 Nagji Bansi · CIK 0001632311 · EVP, Chief Strategy & BD Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,487 F1 · shares: This transaction represents the settlement of performance stock units ("PSUs") which vested upon attainment of performance goals. Read SEC document |
| November 09, 2018 Filed Nov 13, 2018 23:22 UTC | MCKESSON CORP MCK · Entity 2904 | GrantRestricted Stock Units (RSUs) · Derivative | 19,112 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001444054-18-000035 · edgar.xml · derivative · entry 1 Nagji Bansi · CIK 0001632311 · EVP, Chief Strategy & BD Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,112 Underlying: Common Stock · 19,112 shares Expires not disclosed F1 · derivative.exercise_date: These RSUs will vest 100% on 11/9/2021. F1 · derivative.expiration_date: These RSUs will vest 100% on 11/9/2021. Read SEC document |
| May 30, 2018 Filed May 31, 2018 22:26 UTC | MCKESSON CORP MCK · Entity 2904 | GrantEmployee Stock Option (Right-to-buy) · Derivative | 16,864 | $0.00 Strike: $144.43 | $0.00 |
DisclosureSEC source: 0001444054-18-000020 · edgar.xml · derivative · entry 1 Nagji Bansi · CIK 0001632311 · EVP, Corp Strategy & Bus. Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,864 Underlying: Common Stock · 16,864 shares Expires 2025-05-30 F1 · derivative.exercise_date: This option granted 5/30/2018 vests 25% annually commencing on the first anniversary of the grant date. Read SEC document |
| January 30, 2018 Filed Jan 31, 2018 22:09 UTC | MCKESSON CORP MCK · Entity 2904 | Exercise / conversionRestricted Stock Units (RSUs) · Derivative | 4,741 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001443873-18-000009 · edgar.xml · derivative · entry 3 Nagji Bansi · CIK 0001632311 · EVP, Corp Strategy & Bus. Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,741 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: RSU award granted 1/30/2017 for 4,741 shares vested 100% on 1/30/2018. F2 · derivative.expiration_date: RSU award granted 1/30/2017 for 4,741 shares vested 100% on 1/30/2018. Read SEC document |
| January 30, 2018 Filed Jan 31, 2018 22:09 UTC | MCKESSON CORP MCK · Entity 2904 | Tax withholdingCommon Stock | 1,661 | $171.75 | $285,276.75 |
DisclosureSEC source: 0001443873-18-000009 · edgar.xml · nonDerivative · entry 2 Nagji Bansi · CIK 0001632311 · EVP, Corp Strategy & Bus. Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,080 F1 · shares: This transaction represents a withholding of shares to cover taxes applicable to a vesting of RSUs also reported on this Form 4. Read SEC document |
| January 30, 2018 Filed Jan 31, 2018 22:09 UTC | MCKESSON CORP MCK · Entity 2904 | Exercise / conversionCommon Stock | 4,741 | $0.00 | $0.00 |
DisclosureSEC source: 0001443873-18-000009 · edgar.xml · nonDerivative · entry 1 Nagji Bansi · CIK 0001632311 · EVP, Corp Strategy & Bus. Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,741 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 23, 2017 Filed May 25, 2017 21:49 UTC | MCKESSON CORP MCK · Entity 2904 | GrantEmployee Stock Option (Right-to-buy) · Derivative | 15,042 | $0.00 Strike: $159.00 | $0.00 |
DisclosureSEC source: 0001444054-17-000004 · edgar.xml · derivative · entry 1 Nagji Bansi · CIK 0001632311 · EVP, Corp Strategy & Bus. Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,042 Underlying: Common Stock · 15,042 shares Expires 2024-05-23 F1 · derivative.exercise_date: This option granted 5/23/2017 vests 25% annually commencing on the first anniversary of the grant date. Read SEC document |
| January 30, 2017 Filed Jan 31, 2017 22:34 UTC | MCKESSON CORP MCK · Entity 2904 | GrantRestricted Stock Units (RSUs) · Derivative | 4,741 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001444054-17-000001 · edgar.xml · derivative · entry 1 Nagji Bansi · CIK 0001632311 · EVP, Corp Strategy & Bus. Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,741 Underlying: Common Stock · 4,741 shares Expires not disclosed F1 · derivative.exercise_date: These units granted 01/30/2017 will vest 100% on the first anniversary of the grant date. F1 · derivative.expiration_date: These units granted 01/30/2017 will vest 100% on the first anniversary of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.